Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Indivior PLC

Market Cap 4.67B 4.07B 3.75B 3.53B 6.6B 440B 6.65B 44.62B 17.33B 217B 17.53B 17.15B 752B P/E 2026 *
12.1x
P/E 2027 * 11.1x
Enterprise Value 4.72B 4.12B 3.79B 3.57B 6.68B 445B 6.72B 45.14B 17.53B 219B 17.73B 17.35B 760B EV / Sales 2026 *
3.76x
EV / Sales 2027 * 3.31x
Free-Float
94.92%
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-1.82%-1.64% - - 4.67B
-1.21%-5.37%+39.94%+145.38% 980B
-2.48%-4.17%+51.52%+39.07% 550B
-2.14%-3.68%+16.71%+56.15% 382B
-1.18%+0.25%+25.86%+16.53% 317B
-2.36%-3.12%+24.71%+11.59% 270B
-2.45%-2.88%+24.29%+30.06% 269B
-1.91%-0.87%-41.95%-49.25% 191B
-1.19%-4.65%+16.56%+47.00% 182B
-1.35%-1.68%+14.59%+56.94% 154B
Average -1.81%-2.68%+19.14%+39.27% 366B
Weighted average by Cap. -1.77%-3.38%+28.08%+63.68%

Financials

2026 *2027 *
Net sales 1.26B 1.1B 1.01B 950M 1.78B 119B 1.79B 12.02B 4.67B 58.42B 4.72B 4.62B 202B 1.29B 1.12B 1.03B 973M 1.82B 121B 1.83B 12.3B 4.78B 59.79B 4.83B 4.73B 207B
Net income 414M 361M 333M 313M 586M 39.06B 590M 3.96B 1.54B 19.25B 1.56B 1.52B 66.72B 455M 396M 365M 344M 643M 42.87B 647M 4.35B 1.69B 21.13B 1.71B 1.67B 73.23B
Net Debt 54.5M 47.49M 43.77M 41.17M 77.03M 5.14B 77.57M 521M 202M 2.53B 205M 200M 8.77B -403M -351M -324M -305M -570M -38.02B -574M -3.85B -1.5B -18.74B -1.51B -1.48B -64.94B
Logo Indivior PLC
Indivior Pharmaceuticals, Inc. is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. It sells its products in the United States and in other selected areas of the world.
Employees
833
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!